Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-30

Clinical Trial Update: Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for albiglutide liquid product in type 2 diabetes shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albiglutide (albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2018-05-30